Why insider trading matters?
If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.
PDL BioPharma, Inc. acquires, manages, and commercializes commercial stage pharmaceutical assets and late clinical stage pharmaceutical products in North America, Europe, Asia, and internationally. The company operates through Medical Devices, Strategic Positions, Pharmaceutical, and Income Generating Assets segments. The Pharmaceutical segment manufactures, markets, and sells prescription medicine products for the treatment of hypertension to wholesalers under the Tekturna and Tekturna HCT names in the United States, as well as under the Rasilez and Rasilez HCT names internationally. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2021-02-01 | Silver Point Capital L.P. | 10%-Owner | Buy | 187,061 | $2.05 | $383,475 | No |
| 2020-12-30 | Silver Point Capital L.P. | 10%-Owner | Buy | 6,325,213 | $2.50 | $15,813,032 | No |
| 2020-12-30 | GRYSKA DAVID W | Director | Sell | 20,000 | $2.74 | $54,800 | No |
| 2020-12-29 | Silver Point Capital L.P. | 10%-Owner | Buy | 631,600 | $2.69 | $1,696,234 | No |
| 2020-12-23 | Silver Point Capital L.P. | 10%-Owner | Buy | 1,565,000 | $2.60 | $4,067,400 | No |
| 2020-12-22 | MCLAUGHLIN JOHN PETER | Director | Sell | 327,934 | $2.61 | $855,774 | No |
| 2020-12-17 | Silver Point Capital L.P. | 10%-Owner | Buy | 1,748,000 | $2.59 | $4,521,780 | No |
| 2020-12-16 | Stone Christopher Lewis | VP, Gen. Counsel & Secretary | Sell | 200,000 | $2.56 | $512,000 | No |
| 2020-12-16 | Monnet Dominique | President and CEO | Sell | 500,000 | $2.60 | $1,300,000 | No |
| 2020-12-16 | GRYSKA DAVID W | Director | Sell | 75,000 | $2.68 | $201,000 | No |
| 2020-12-15 | Silver Point Capital L.P. | 10%-Owner | Buy | 2,090,000 | $2.57 | $5,369,300 | No |
| 2020-12-03 | GRYSKA DAVID W | Director | Sell | 75,000 | $2.52 | $189,000 | No |
| 2020-11-23 | O'Farrell Elizabeth G. | Director | Sell | 25,826 | $2.44 | $63,015 | No |
| 2020-11-23 | GRYSKA DAVID W | Director | Sell | 50,000 | $2.43 | $121,500 | No |
| 2020-11-18 | O'Farrell Elizabeth G. | Director | Sell | 63,291 | $2.38 | $150,696 | No |
| 2020-11-20 | Bazaar Alan Lee | Director | Sell | 33,435 | $2.42 | $81,003 | Yes |
| 2020-11-18 | GRYSKA DAVID W | Director | Sell | 150,000 | $2.40 | $359,500 | No |
| 2019-06-10 | PDL BIOPHARMA, INC. | 10%-Owner | Buy | 6,666,667 | $4.50 | $30,000,002 | Yes |
| 2017-03-24 | GARCIA PETER S | Vice President, CFO | Buy | 25,000 | $1.98 | $49,401 | No |
| 2016-08-09 | GARCIA PETER S | Vice President, CFO | Buy | 10,000 | $3.00 | $29,950 | No |
| 2015-12-15 | GARCIA PETER S | Vice President, CFO | Buy | 15,000 | $3.50 | $52,444 | No |
| 2015-12-07 | Pietzke Steffen | Controller and CAO | Buy | 20,590 | $3.64 | $74,931 | No |
| 2015-08-14 | GARCIA PETER S | Vice President, CFO | Buy | 20,000 | $5.83 | $116,502 | No |
| 2014-11-26 | SELICK HAROLD E | Director | Buy | 6,000 | $8.08 | $48,487 | No |
| 2011-03-15 | Lindell Jody S | Director | Buy | 374 | $5.33 | $1,992 | No |
| 2010-05-14 | LARSON CHRISTINE R | Vice President and CFO | Buy | 5,000 | $5.71 | $28,544 | No |
| 2010-04-30 | LARSON CHRISTINE R | Vice President and CFO | Buy | 10,000 | $6.18 | $61,830 | No |
| 2009-11-04 | KLEIN JOSEPH III | Director | Sell | 24,000 | $8.33 | $199,815 | Yes |
| 2009-06-15 | Lindell Jody S | Director | Buy | 3,000 | $7.76 | $23,280 | No |
| 2009-04-08 | SANDMAN PAUL W | Director | Buy | 10,000 | $7.38 | $73,822 | No |
Insider Smart
Insider Smart